Healthcare >> CEO Interviews >> October 12, 2001

Robert Conway – Array Biopharma Inc (arry)

ROBERT E. CONWAY has served as Chief Executive Officer for Array BioPharma Inc., since November 1999 and as a member of the Board of Directors since December 1999. He manages the fast growing 245 employee drug discovery company in Boulder, Colorado, where he led the organization through its IPO in November 2000. Prior to joining Array, Mr. Conway was the Chief Operating Officer and Executive Vice President of Hill Top Research, from 1996 to 1999. There he managed 22 company- owned research centers, conducting clinical trials for pharmaceutical and biotechnology companies. From 1979 until 1996, Mr. Conway held various executive positions for Corning, most recently as the Corporate Vice President and General Manager of Corning Hazleton, the world's largest preclinical contract research organization. There, he led North American operations consisting of two state-of-the-art laboratories, three worldwide sales offices and over 1,000 employees. Mr. Conway currently serves on the Board of Directors of DEMCO. He has also served as Chairman of the Greater Madison Chamber of Commerce in Madison, and as a Board member of the Board of Visitors at the University of Wisconsin-Madison School of Business and School of Pharmacy, the Wisconsin Council for Science and Technology, and Future Madison Inc. Mr. Conway received a BS in Accounting from Marquette University and an MBA from the University of Cincinnati. Profile
TWST: Could we begin with a brief overview and history of the evolution

of Array BioPharma?

Mr. Conway: Array BioPharma is a drug discovery company creating new

drugs through innovations in